Clinical Trial Update: Study to Evaluate Efficacy/Safety of Combination Budesonide/Indacaterol vs Fluticasone/Salmeterol in Patients With COPD [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing budesonide/indacaterol versus fluticasone/salmeterol in COPD has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Budesonide/Indacaterol (budesonide + indacaterol)
• Fluticasone/Salmeterol (fluticasone/salmeterol)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED | Results posted: 2017-04-18